|
[1]
|
Davenport DL, Ferraris VA, Hosokawa P, et al. Multivaria-ble predictors of postoperative cardiac adverse events after general and vascular surgery:results from the patient safety in surgery study[J]. J Am Coll Surg, 2007, 204:1199-1210. doi: 10.1016/j.jamcollsurg.2007.02.065 |
|
[2]
|
Kheterpal S, O'Reilly M, Englesbe MJ, et al. Preoperative and intraoperative predictors of cardiac adverse events after general, vascular, and urological surgery[J]. Anesthesio-logy, 2009, 110:58-66. doi: 10.1097/ALN.0b013e318190b6dc |
|
[3]
|
Poldermans D, Hoeks SE, Feringa HH. Pre-operative risk assessment and risk reduction before surgery[J]. JACC, 2008, 51:1913-1924. doi: 10.1016/j.jacc.2008.03.005 |
|
[4]
|
Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures[J]. N Engl J Med, 1977, 297:845-850. doi: 10.1056/NEJM197710202971601 |
|
[5]
|
Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery[J]. Circulation, 1999, 100:1043-1049. doi: 10.1161/01.CIR.100.10.1043 |
|
[6]
|
Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery:a report of the American College of Cardiology/American Heart Association task force on practice guidelines[J]. Circulation, 2009, 120:169-276. |
|
[7]
|
Bai J, Hashimoto J, Nakahara T, et al. Influence of ageing on perioperative cardiac risk in noncardiac surgery[J]. Age Ageing, 2007, 36:68-72. |
|
[8]
|
Puig-Barbera J, Marquez-Calderon S, Vila-Sanchez M. Cardiac complications of major elective non-cardiac surgery:incidence and risk factors[J]. Rev Esp Cardiol, 2006, 59:329-337. doi: 10.1157/13087065 |
|
[9]
|
Falcone RA, Nass C, Jermyn R, et al. The value of pre-operative pharmacologic stress testing before vascular surgery using ACC/AHA guidelines:a prospective, randomized trial[J]. J Cardiothorac Vasc Anesth, 2003, 17:694-698. doi: 10.1053/j.jvca.2003.09.004 |
|
[10]
|
Khaled MM, Hani MT, Toby R, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery:a retrospective cohort study[J]. Lancet, 2011, 378:1396-1407. doi: 10.1016/S0140-6736(11)61381-0 |
|
[11]
|
Mangano DT. Perioperative cardiac morbidity[J]. Anesthesiology, 1990, 72:153-184. doi: 10.1097/00000542-199001000-00025 |
|
[12]
|
Vineet C, Kim AE. Perioperative β-blockers for cardiac risk reduction:time for clarity[J]. JAMA, 2010, 303:551-552. doi: 10.1001/jama.2010.68 |
|
[13]
|
Mudumbai SC, Wagner T, Mahajan S, et al.Vascular surgery patients prescribed preoperative β-blockers experienced a decrease in the maximal heart rate observed during induction of general anesthesia[J]. J Cardiothorac Vasc Anesth, 2012, 26:414-419. doi: 10.1053/j.jvca.2011.09.027 |
|
[14]
|
Angeli F, Verdecchia P, Karthikeyan G, et al.β-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery[J]. Am J Cardiovasc Drug, 2010, 10:247-259. doi: 10.2165/11539510-000000000-00000 |
|
[15]
|
Fabio A, Gianpaolo R, Paolo V. Good news for beta-blockers in perioperative medicine[J]. Expert Opin Drug Saf, 2011, 10:491-498. doi: 10.1517/14740338.2011.560113 |
|
[16]
|
Flynnl BC, Vernick WJ, Ellis JE. β-blockade in the peri-operative management of the patient with cardiac disease undergoing non-cardiac surgery[J]. Br J Anaesth, 2011, 107:i3-i15. doi: 10.1093/bja/aer380 |
|
[17]
|
Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch echocardiographic cardiac risk evaluation applying stress echocardiography study group[J]. N Engl J Med, 1999, 341:1789-1794. doi: 10.1056/NEJM199912093412402 |
|
[18]
|
Boersma E, Poldermans D, Bax JJ, et al. Predictors of cardiac events after major vascular surgery:role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy[J]. JAMA, 2001, 285:1865-1873. doi: 10.1001/jama.285.14.1865 |
|
[19]
|
Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery[J]. N Engl J Med, 2005, 353:349-361. doi: 10.1056/NEJMoa041895 |
|
[20]
|
Dunkelgrun M, Boersma E, Schouten O, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery:a randomized controlled trial (DECREASE-Ⅳ)[J]. Ann Surg, 2009, 249:921-926. doi: 10.1097/SLA.0b013e3181a77d00 |
|
[21]
|
Juul AB, Wetterslev J, Gluud C, et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery:randomised placebo controlled, blinded multicentre trial[J]. BMJ, 2006, 332:1482-1488. doi: 10.1136/bmj.332.7556.1482 |
|
[22]
|
Yang H, Raymer K, Butler R, et al. The effects of perioperative beta-blockade:results of the metoprolol after vascular surgery (MaVS) study, a randomized controlled trial[J]. Am Heart J, 2006, 152:983-990. doi: 10.1016/j.ahj.2006.07.024 |
|
[23]
|
POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial):a randomized controlled trial[J]. Lancet, 2008, 371:1839-1847. doi: 10.1016/S0140-6736(08)60601-7 |
|
[24]
|
Beattie WS, Wijeysundera DN, Karkouti K, et al. Acute surgical anemia influences the cardioprotective effects of β-blockade[J]. Anesthesiology, 2010, 112:25-33. doi: 10.1097/ALN.0b013e3181c5dd81 |
|
[25]
|
Niels JCR, Michiel TV, Poldermans D. Safety of perioperative β-blocker use:how do β-blockers compare in terms of side effects?[J]. Expert Opin Drug Saf, 2011, 10:545-558. doi: 10.1517/14740338.2011.552500 |
|
[26]
|
Kleinman B, Jellish WS, Wall MJ, et al. Failure to achieve target heart rates during perioperative beta blockade for noncardiac surgery[J]. J Clin Outcomes Manage, 2012, 19:61-66. |
|
[27]
|
Fleisher LA, Poldermans D. Perioperative β blockade:where do we go from here?[J]. Lancet, 2008, 371:1813-1814. doi: 10.1016/S0140-6736(08)60662-5 |
|
[28]
|
Steve K, Rachel T, Michael F, et al. β-blocker continuation after noncardiac surgery:a report from the surgical care and outcomes assessment program[J]. Arch Surg, 2012, 147:467-473. doi: 10.1001/archsurg.2011.1698 |
|
[29]
|
Hoeks SE, Scholte Op Reimer WJ, van Urk H, et al. Increase of 1-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients[J]. Eur J Vasc Endovasc Surg, 2007, 33:13-19. doi: 10.1016/j.ejvs.2006.06.019 |
|
[30]
|
Cruickshank JM. Are we misunderstanding beta-blockers?[J]. Int J Cardiol, 2007, 120:10-27. doi: 10.1016/j.ijcard.2007.01.069 |
|
[31]
|
Seeland U, Selejan S, Engelhardt S, et al. Interstitial remodeling in beta1-adrenergic receptor transgenic mice[J]. Basic Res Cardiol, 2007, 102:183-193. doi: 10.1007/s00395-006-0635-y |
|
[32]
|
Communal C, Singh K, Sawyer DB, et al. Opposing effects of beta(1)-and beta(2)-adrenergic receptors on cardiac myocyte apoptosis:role of a pertussis toxin-sensitive G protein[J]. Circulation, 1999, 100:2210-2212. doi: 10.1161/01.CIR.100.22.2210 |
|
[33]
|
Arthur WW, Selwyn A, Brian AC. Perioperative β-blockade:atenolol is associated with reduced mortality when compared to metoprolol[J].Anesthesiology, 2011, 114:824-836. doi: 10.1097/ALN.0b013e3182110e83 |
|
[34]
|
Shammash JB, Trost JC, Gold JM, et al. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients[J]. Am Heart J, 2001, 141:148-153. doi: 10.1067/mhj.2001.111547 |
|
[35]
|
Willem-Jan F, Jan-Peter van K, Michel C, et al. Timing of pre-operative beta-blocker treatment in vascular surgery patients, influence on post-operative outcome[J]. J Am Coll Cardiol, 2010, 56:1922-1929. doi: 10.1016/j.jacc.2010.05.056 |
作者投稿
专家审稿
编辑办公
邮件订阅
RSS
点击查看大图
下载:
